#Keytruda - another one of those drug-commercials where the side-effects far outnumber the reliefs | @Merck @HeavySan @Labiotech_eu @JournalOfEthics
'That name' (below-hyperlinked to a list of side-effects that accompany the immunotherapy that "cured" President Jimmy Carter's cancer (well, it's not 'cured'; but it definitely trained his immune-system to beat the cancer into remission)) is built on an even-deeper source ... something crucial that firms the foundation upon which our lexicon stands ...
The word “Keytruda” (trade-name for generic #Pembrolizumab) is built on ... I don't know (but I'm still trying to find)—but I'm guessing it has something to do with discoveries at |Kyoto University; ... maybe I'll pick up some clues if I read through the Drugs.com-page remembering its FDA approval-history, 'taking notes' here).
It's a human PD-1 (programmed death receptor-1)-blocking antibody used as treatment for: Melanoma (Metastatic), Non-Small Cell Lung Cancer, Head and Neck Cancer, Hodgkin's Lymphoma, Urothelial Carcinoma, Gastric Cancer, Cervical Cancer, Hepatocellular Carcinoma, Merkel Cell Carcinoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Esophageal Carcinoma, Endometrial Cancer, Squamous Cell Carcinoma;
ehh ... I can't find anything. Do you know the meanings behind
SUBSCRIBE FREE below:
LungMerck's response to coronavirus (COVID-19)
During this unprecedented time, Merck is committed to ensuring our medicines and vaccines reach our patients and customers. This includes supporting patients who might need more help today with their medications, including those who are unemployed or have lost insurance coverage due to the COVID-19 pandemic. To learn about what support options may be available, visit our Access and Patient Assistance information page.For more detail about Merck's response to coronavirus, visit our COVID-19 information page.
Comments
Post a Comment
I appreciate your comment, and I'll probably approve it & publish it soon (give me about a week before you try to post it again when it doesn't publish immediately ... thanks)